EQUIMED 250 product packaging
Deus Medical logo

EQUIMED 250 (Boldenone Undecylenate)

CAS number: 13103-34-9
Molecular Weight: 452.67 g/mol
• Chemical Formula: C18H22O2

Authenticity protected scan our product QR code


EQUIMED 250 (Boldenone Undecylenate)

EQUIMED 250 product packaging


EQUIMED 250 (Boldenone Undecylenate) has both androgenic and anabolic properties (AAS), but is majorly used due to its potent anabolic activity. It is used to stimulate protein synthesis and appetite and also has an effect on erythropoietin for the treatment of anemias. EQUIMED 250 comes as boldenone undecylenate 250mg/ml injection, which contains boldenone undecylenate 250mg and excipients. 

Boldenone Undecylenate Mechanism of Action

Boldenone undecylenate is a prodrug (inactive form) which is eventually converted into its active form boldenone. It acts on the androgen receptor to elicit its anabolic effects. It also stimulates the kidneys to produce erythropoietin which stimulates the bone marrow to produce more red blood cells. It does not have progestogenic effects. It has a half-life of 14 days when given as an injection via the intramuscular route.

Boldenone Undecylenate Dosage

100mg - 200mg weekly given as intramuscular injection.

Boldenone Undecylenate Side Effects

Side effects include acne, virilization, gynecomastia, fluid retention, and scalp hair loss.

Boldenone Undecylenate Interactions

Boldenone Undecylenate interacts with estrogen grape seed extract.  


? Boldenone Undecylenate . . . 250mg
? Excipients . . . . . . . . . . . . . . . . . . . . . q.s

EQUIMED 250 back of the product pack
Authenticity protected scan our product QR code


We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.